Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1979 1
1982 2
1983 1
1984 2
1985 5
1986 2
1987 2
1988 3
1989 3
1990 4
1991 4
1992 10
1993 15
1994 12
1995 13
1996 13
1997 13
1998 9
1999 8
2000 13
2001 5
2002 11
2003 14
2004 5
2005 9
2006 4
2007 12
2008 8
2009 8
2010 13
2011 17
2012 11
2013 16
2014 8
2015 10
2016 13
2017 7
2018 9
2019 11
2020 10
2021 4
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

321 results
Results by year
Filters applied: . Clear all
Page 1
CAR T Cell Therapy for Solid Tumors.
Newick K, O'Brien S, Moon E, Albelda SM. Newick K, et al. Among authors: albelda sm. Annu Rev Med. 2017 Jan 14;68:139-152. doi: 10.1146/annurev-med-062315-120245. Epub 2016 Nov 17. Annu Rev Med. 2017. PMID: 27860544 Review.
Targeting cardiac fibrosis with engineered T cells.
Aghajanian H, Kimura T, Rurik JG, Hancock AS, Leibowitz MS, Li L, Scholler J, Monslow J, Lo A, Han W, Wang T, Bedi K, Morley MP, Linares Saldana RA, Bolar NA, McDaid K, Assenmacher CA, Smith CL, Wirth D, June CH, Margulies KB, Jain R, Puré E, Albelda SM, Epstein JA. Aghajanian H, et al. Among authors: albelda sm. Nature. 2019 Sep;573(7774):430-433. doi: 10.1038/s41586-019-1546-z. Epub 2019 Sep 11. Nature. 2019. PMID: 31511695 Free PMC article.
An NK-like CAR T cell transition in CAR T cell dysfunction.
Good CR, Aznar MA, Kuramitsu S, Samareh P, Agarwal S, Donahue G, Ishiyama K, Wellhausen N, Rennels AK, Ma Y, Tian L, Guedan S, Alexander KA, Zhang Z, Rommel PC, Singh N, Glastad KM, Richardson MW, Watanabe K, Tanyi JL, O'Hara MH, Ruella M, Lacey SF, Moon EK, Schuster SJ, Albelda SM, Lanier LL, Young RM, Berger SL, June CH. Good CR, et al. Among authors: albelda sm. Cell. 2021 Dec 9;184(25):6081-6100.e26. doi: 10.1016/j.cell.2021.11.016. Epub 2021 Dec 2. Cell. 2021. PMID: 34861191 Free article.
Mesothelin-targeted CAR-T cell therapy for solid tumors.
Klampatsa A, Dimou V, Albelda SM. Klampatsa A, et al. Among authors: albelda sm. Expert Opin Biol Ther. 2021 Apr;21(4):473-486. doi: 10.1080/14712598.2021.1843628. Epub 2020 Nov 12. Expert Opin Biol Ther. 2021. PMID: 33176519 Review.
CAR T cells produced in vivo to treat cardiac injury.
Rurik JG, Tombácz I, Yadegari A, Méndez Fernández PO, Shewale SV, Li L, Kimura T, Soliman OY, Papp TE, Tam YK, Mui BL, Albelda SM, Puré E, June CH, Aghajanian H, Weissman D, Parhiz H, Epstein JA. Rurik JG, et al. Among authors: albelda sm. Science. 2022 Jan 7;375(6576):91-96. doi: 10.1126/science.abm0594. Epub 2022 Jan 6. Science. 2022. PMID: 34990237
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients.
Condamine T, Dominguez GA, Youn JI, Kossenkov AV, Mony S, Alicea-Torres K, Tcyganov E, Hashimoto A, Nefedova Y, Lin C, Partlova S, Garfall A, Vogl DT, Xu X, Knight SC, Malietzis G, Lee GH, Eruslanov E, Albelda SM, Wang X, Mehta JL, Bewtra M, Rustgi A, Hockstein N, Witt R, Masters G, Nam B, Smirnov D, Sepulveda MA, Gabrilovich DI. Condamine T, et al. Among authors: albelda sm. Sci Immunol. 2016 Aug;1(2):aaf8943. doi: 10.1126/sciimmunol.aaf8943. Epub 2016 Aug 5. Sci Immunol. 2016. PMID: 28417112 Free PMC article.
Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer.
Singhal S, Stadanlick J, Annunziata MJ, Rao AS, Bhojnagarwala PS, O'Brien S, Moon EK, Cantu E, Danet-Desnoyers G, Ra HJ, Litzky L, Akimova T, Beier UH, Hancock WW, Albelda SM, Eruslanov EB. Singhal S, et al. Among authors: albelda sm. Sci Transl Med. 2019 Feb 13;11(479):eaat1500. doi: 10.1126/scitranslmed.aat1500. Sci Transl Med. 2019. PMID: 30760579 Free PMC article.
321 results